| Dr Vernon William Cantwell, MD | |
|
211 4th St, Alexandria, LA 71301-8421 | |
| (318) 397-1274 | |
| Not Available |
| Full Name | Dr Vernon William Cantwell |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 211 4th St, Alexandria, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033164918 | NPI | - | NPPES |
| 1365670 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 019173 (Louisiana) | Primary |
| Entity Name | Emergency Group Of St Landry Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164491320 PECOS PAC ID: 0749237212 Enrollment ID: O20050406000828 |
News Archive
Bay Area Lyme Foundation, the leading national nonprofit funder of innovative Lyme disease research, today announced that the winners of its 2015 Emerging Leader Award, are collaborators Nira Pollock, MD, PhD, and John Branda, MD.
Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology, to be held on December 4-7 in Orlando, FL, the company announced today. Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.
Small changes in the social lives of older people are early red flags showing that their thought processes and brain functioning could be on the decline. This is according to Ashwin Kotwal of Brigham and Women's Hospital in the US, who led a study¹ in the Journal of General Internal Medicine, published by Springer.
A common class of blood pressure drugs called angiotensin-receptor blockers may be linked with a slightly increased risk of developing cancer, US scientists have found.
› Verified 4 days ago
| Entity Name | Oakdale Ess Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750785119 PECOS PAC ID: 7517289713 Enrollment ID: O20141125000402 |
News Archive
Bay Area Lyme Foundation, the leading national nonprofit funder of innovative Lyme disease research, today announced that the winners of its 2015 Emerging Leader Award, are collaborators Nira Pollock, MD, PhD, and John Branda, MD.
Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology, to be held on December 4-7 in Orlando, FL, the company announced today. Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.
Small changes in the social lives of older people are early red flags showing that their thought processes and brain functioning could be on the decline. This is according to Ashwin Kotwal of Brigham and Women's Hospital in the US, who led a study¹ in the Journal of General Internal Medicine, published by Springer.
A common class of blood pressure drugs called angiotensin-receptor blockers may be linked with a slightly increased risk of developing cancer, US scientists have found.
› Verified 4 days ago
| Entity Name | Leatherwood Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760946313 PECOS PAC ID: 0749521250 Enrollment ID: O20190410002335 |
News Archive
Bay Area Lyme Foundation, the leading national nonprofit funder of innovative Lyme disease research, today announced that the winners of its 2015 Emerging Leader Award, are collaborators Nira Pollock, MD, PhD, and John Branda, MD.
Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology, to be held on December 4-7 in Orlando, FL, the company announced today. Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.
Small changes in the social lives of older people are early red flags showing that their thought processes and brain functioning could be on the decline. This is according to Ashwin Kotwal of Brigham and Women's Hospital in the US, who led a study¹ in the Journal of General Internal Medicine, published by Springer.
A common class of blood pressure drugs called angiotensin-receptor blockers may be linked with a slightly increased risk of developing cancer, US scientists have found.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vernon William Cantwell, MD 200 Corporate Blvd, Lafayette, LA 70508-3870 Ph: (800) 893-9698 | Dr Vernon William Cantwell, MD 211 4th St, Alexandria, LA 71301-8421 Ph: (318) 397-1274 |
News Archive
Bay Area Lyme Foundation, the leading national nonprofit funder of innovative Lyme disease research, today announced that the winners of its 2015 Emerging Leader Award, are collaborators Nira Pollock, MD, PhD, and John Branda, MD.
Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology, to be held on December 4-7 in Orlando, FL, the company announced today. Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.
Small changes in the social lives of older people are early red flags showing that their thought processes and brain functioning could be on the decline. This is according to Ashwin Kotwal of Brigham and Women's Hospital in the US, who led a study¹ in the Journal of General Internal Medicine, published by Springer.
A common class of blood pressure drugs called angiotensin-receptor blockers may be linked with a slightly increased risk of developing cancer, US scientists have found.
› Verified 4 days ago
Dr. Dave Daigle Jr., Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 4th St, Alexandria, LA 71301 Phone: 800-893-9698 | |
Kelvin Spears, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Masonic Dr, Alexandria, LA 71301 Phone: 800-639-2519 Fax: 985-447-8556 | |
Joseph Hathorn, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3330 Masonic Dr, Alexandria, LA 71301 Phone: 800-639-2519 Fax: 985-447-8556 | |
Gloria Laws, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 301 4th St, Alexandria, LA 71301 Phone: 318-441-1041 | |
Larry Parker, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Masonic Dr, Alexandria, LA 71301 Phone: 800-639-2519 Fax: 985-447-8556 | |
Dr. James Huey Hebert, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Masonic Dr, Alexandria, LA 71301 Phone: 318-448-6750 |